Annual Net Income
-$263.30 M
-$151.30 M-135.09%
01 December 2023
Summary:
Myriad Genetics annual net profit is currently -$263.30 million, with the most recent change of -$151.30 million (-135.09%) on 01 December 2023. During the last 3 years, it has fallen by -$210.20 million (-395.86%). MYGN annual net income is now -249.43% below its all-time high of $176.20 million, reached on 30 June 2014.MYGN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$22.10 M
+$14.60 M+39.78%
01 September 2024
Summary:
Myriad Genetics quarterly net profit is currently -$22.10 million, with the most recent change of +$14.60 million (+39.78%) on 01 September 2024. Over the past year, it has increased by +$39.20 million (+63.95%). MYGN quarterly net income is now -128.05% below its all-time high of $78.80 million, reached on 30 September 2017.MYGN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$116.00 M
+$39.20 M+25.26%
01 September 2024
Summary:
Myriad Genetics TTM net profit is currently -$116.00 million, with the most recent change of +$39.20 million (+25.26%) on 01 September 2024. Over the past year, it has increased by +$158.40 million (+57.73%). MYGN TTM net income is now -161.75% below its all-time high of $187.85 million, reached on 31 December 2013.MYGN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MYGN Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -135.1% | +64.0% | +57.7% |
| 3 y3 years | -395.9% | -189.8% | -491.8% |
| 5 y5 years | -5823.9% | -7.3% | -658.2% |
MYGN Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -868.0% | at low | -189.8% | +81.0% | -1314.6% | +57.7% |
| 5 y | 5 years | -5823.9% | at low | -189.8% | +81.0% | -1314.6% | +57.7% |
| alltime | all time | -249.4% | at low | -128.1% | +81.0% | -161.8% | +57.7% |
Myriad Genetics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$22.10 M(-39.8%) | -$116.00 M(-25.3%) |
| June 2024 | - | -$36.70 M(+41.2%) | -$155.20 M(-33.8%) |
| Mar 2024 | - | -$26.00 M(-16.7%) | -$234.60 M(-10.9%) |
| Dec 2023 | -$263.30 M(+135.1%) | -$31.20 M(-49.1%) | -$263.30 M(-4.0%) |
| Sept 2023 | - | -$61.30 M(-47.2%) | -$274.40 M(+10.6%) |
| June 2023 | - | -$116.10 M(+112.2%) | -$248.20 M(+69.8%) |
| Mar 2023 | - | -$54.70 M(+29.3%) | -$146.20 M(+30.5%) |
| Dec 2022 | -$112.00 M(+311.8%) | -$42.30 M(+20.5%) | -$112.00 M(+44.9%) |
| Sept 2022 | - | -$35.10 M(+148.9%) | -$77.30 M(+339.2%) |
| June 2022 | - | -$14.10 M(-31.2%) | -$17.60 M(+114.6%) |
| Mar 2022 | - | -$20.50 M(+169.7%) | -$8.20 M(-69.9%) |
| Dec 2021 | -$27.20 M(-48.8%) | -$7.60 M(-130.9%) | -$27.20 M(+38.8%) |
| Sept 2021 | - | $24.60 M(-623.4%) | -$19.60 M(-67.0%) |
| June 2021 | - | -$4.70 M(-88.1%) | -$59.40 M(-46.0%) |
| Mar 2021 | - | -$39.50 M(+159.9%) | -$110.10 M(-43.3%) |
| Dec 2020 | -$53.10 M(-73.4%) | - | - |
| Sept 2020 | - | -$15.20 M(-72.6%) | -$194.10 M(-2.7%) |
| June 2020 | -$199.50 M(-4437.0%) | -$55.40 M(-51.9%) | -$199.50 M(+34.5%) |
| Mar 2020 | - | -$115.20 M(+1288.0%) | -$148.30 M(+466.0%) |
| Dec 2019 | - | -$8.30 M(-59.7%) | -$26.20 M(+71.2%) |
| Sept 2019 | - | -$20.60 M(+390.5%) | -$15.30 M(-432.6%) |
| June 2019 | $4.60 M(-96.5%) | -$4.20 M(-160.9%) | $4.60 M(-80.2%) |
| Mar 2019 | - | $6.90 M(+165.4%) | $23.20 M(-8.7%) |
| Dec 2018 | - | $2.60 M(-471.4%) | $25.40 M(-52.7%) |
| Sept 2018 | - | -$700.00 K(-104.9%) | $53.70 M(-59.7%) |
| June 2018 | $133.30 M(+666.1%) | $14.40 M(+58.2%) | $133.20 M(+4.7%) |
| Mar 2018 | - | $9.10 M(-70.6%) | $127.20 M(+4.0%) |
| Dec 2017 | - | $30.90 M(-60.8%) | $122.30 M(+25.7%) |
| Sept 2017 | - | $78.80 M(+838.1%) | $97.30 M(+462.4%) |
| June 2017 | $17.40 M(-85.2%) | $8.40 M(+100.0%) | $17.30 M(-28.2%) |
| Mar 2017 | - | $4.20 M(-28.8%) | $24.10 M(-55.7%) |
| Dec 2016 | - | $5.90 M(-591.7%) | $54.40 M(-36.4%) |
| Sept 2016 | - | -$1.20 M(-107.9%) | $85.60 M(-26.9%) |
| June 2016 | $117.20 M(+46.1%) | $15.20 M(-55.9%) | $117.10 M(-2.9%) |
| Mar 2016 | - | $34.50 M(-7.0%) | $120.60 M(+12.2%) |
| Dec 2015 | - | $37.10 M(+22.4%) | $107.50 M(+13.9%) |
| Sept 2015 | - | $30.30 M(+62.0%) | $94.40 M(+17.9%) |
| June 2015 | $80.20 M(-54.5%) | $18.70 M(-12.6%) | $80.10 M(-15.7%) |
| Mar 2015 | - | $21.40 M(-10.8%) | $95.01 M(-13.9%) |
| Dec 2014 | - | $24.00 M(+50.0%) | $110.38 M(-19.3%) |
| Sept 2014 | - | $16.00 M(-52.4%) | $136.74 M(-22.4%) |
| June 2014 | $176.20 M(+19.7%) | $33.61 M(-8.6%) | $176.20 M(-5.6%) |
| Mar 2014 | - | $36.77 M(-27.0%) | $186.73 M(-0.6%) |
| Dec 2013 | - | $50.36 M(-9.2%) | $187.85 M(+8.9%) |
| Sept 2013 | - | $55.47 M(+25.7%) | $172.53 M(+17.2%) |
| June 2013 | $147.20 M(+31.3%) | $44.13 M(+16.5%) | $147.20 M(+11.3%) |
| Mar 2013 | - | $37.89 M(+8.2%) | $132.21 M(+6.7%) |
| Dec 2012 | - | $35.04 M(+16.3%) | $123.93 M(+5.8%) |
| Sept 2012 | - | $30.14 M(+3.4%) | $117.19 M(+4.5%) |
| June 2012 | $112.15 M(+11.4%) | $29.14 M(-1.6%) | $112.15 M(+2.8%) |
| Mar 2012 | - | $29.61 M(+4.7%) | $109.05 M(+1.6%) |
| Dec 2011 | - | $28.30 M(+12.7%) | $107.38 M(+4.0%) |
| Sept 2011 | - | $25.10 M(-3.6%) | $103.27 M(+2.5%) |
| June 2011 | $100.71 M(-33.9%) | $26.04 M(-6.8%) | $100.71 M(-21.3%) |
| Mar 2011 | - | $27.94 M(+15.5%) | $127.92 M(-4.0%) |
| Dec 2010 | - | $24.19 M(+7.3%) | $133.23 M(-7.7%) |
| Sept 2010 | - | $22.54 M(-57.7%) | $144.40 M(-5.2%) |
| June 2010 | $152.30 M | $53.25 M(+60.1%) | $152.30 M(+24.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $33.25 M(-6.0%) | $122.69 M(+6.9%) |
| Dec 2009 | - | $35.36 M(+16.2%) | $114.76 M(+14.1%) |
| Sept 2009 | - | $30.44 M(+28.8%) | $100.60 M(+18.9%) |
| June 2009 | $84.61 M(+76.9%) | $23.64 M(-6.6%) | $84.61 M(-33.1%) |
| Mar 2009 | - | $25.32 M(+19.4%) | $126.52 M(+31.0%) |
| Dec 2008 | - | $21.20 M(+46.7%) | $96.57 M(+37.4%) |
| Sept 2008 | - | $14.45 M(-77.9%) | $70.30 M(+46.9%) |
| June 2008 | $47.84 M(-236.8%) | $65.54 M(-1515.3%) | $47.84 M(-287.6%) |
| Mar 2008 | - | -$4.63 M(-8.6%) | -$25.50 M(-4.9%) |
| Dec 2007 | - | -$5.07 M(-36.7%) | -$26.81 M(-12.2%) |
| Sept 2007 | - | -$8.00 M(+2.5%) | -$30.54 M(-12.7%) |
| June 2007 | -$34.96 M(-8.5%) | -$7.80 M(+31.4%) | -$34.96 M(-9.4%) |
| Mar 2007 | - | -$5.94 M(-32.5%) | -$38.58 M(-8.6%) |
| Dec 2006 | - | -$8.80 M(-29.2%) | -$42.22 M(+2.0%) |
| Sept 2006 | - | -$12.43 M(+8.8%) | -$41.37 M(+8.3%) |
| June 2006 | -$38.19 M(-4.5%) | -$11.42 M(+19.4%) | -$38.19 M(+4.0%) |
| Mar 2006 | - | -$9.57 M(+20.4%) | -$36.72 M(-1.1%) |
| Dec 2005 | - | -$7.95 M(-14.0%) | -$37.13 M(-5.3%) |
| Sept 2005 | - | -$9.24 M(-7.1%) | -$39.23 M(-1.9%) |
| June 2005 | -$39.98 M(-1.6%) | -$9.95 M(-0.3%) | -$39.98 M(-1.3%) |
| Mar 2005 | - | -$9.99 M(-0.6%) | -$40.49 M(-1.7%) |
| Dec 2004 | - | -$10.05 M(+0.6%) | -$41.20 M(+0.5%) |
| Sept 2004 | - | -$9.99 M(-4.5%) | -$41.00 M(+0.9%) |
| June 2004 | -$40.62 M(+63.6%) | -$10.46 M(-2.2%) | -$40.62 M(+9.1%) |
| Mar 2004 | - | -$10.70 M(+8.5%) | -$37.24 M(+16.1%) |
| Dec 2003 | - | -$9.85 M(+2.5%) | -$32.08 M(+10.2%) |
| Sept 2003 | - | -$9.61 M(+35.7%) | -$29.12 M(+17.3%) |
| June 2003 | -$24.82 M(+77.5%) | -$7.08 M(+28.0%) | -$24.82 M(+0.9%) |
| Mar 2003 | - | -$5.53 M(-19.7%) | -$24.59 M(+9.0%) |
| Dec 2002 | - | -$6.89 M(+29.7%) | -$22.55 M(+24.5%) |
| Sept 2002 | - | -$5.32 M(-22.4%) | -$18.12 M(+29.5%) |
| June 2002 | -$13.99 M(+95.0%) | -$6.85 M(+95.9%) | -$13.99 M(+50.0%) |
| Mar 2002 | - | -$3.50 M(+42.1%) | -$9.33 M(+23.4%) |
| Dec 2001 | - | -$2.46 M(+107.6%) | -$7.56 M(+20.2%) |
| Sept 2001 | - | -$1.19 M(-45.8%) | -$6.29 M(-12.3%) |
| June 2001 | -$7.17 M(-17.7%) | -$2.19 M(+26.5%) | -$7.17 M(-5.0%) |
| Mar 2001 | - | -$1.73 M(+45.3%) | -$7.55 M(-4.6%) |
| Dec 2000 | - | -$1.19 M(-42.6%) | -$7.91 M(-8.2%) |
| Sept 2000 | - | -$2.07 M(-19.3%) | -$8.62 M(-1.5%) |
| June 2000 | -$8.72 M(-12.8%) | -$2.56 M(+22.7%) | -$8.75 M(+3.1%) |
| Mar 2000 | - | -$2.09 M(+10.0%) | -$8.49 M(-1.3%) |
| Dec 1999 | - | -$1.90 M(-13.6%) | -$8.60 M(-10.4%) |
| Sept 1999 | - | -$2.20 M(-4.3%) | -$9.60 M(-5.0%) |
| June 1999 | -$10.00 M(+2.0%) | -$2.30 M(+4.5%) | -$10.10 M(-7.3%) |
| Mar 1999 | - | -$2.20 M(-24.1%) | -$10.90 M(-3.5%) |
| Dec 1998 | - | -$2.90 M(+7.4%) | -$11.30 M(+5.6%) |
| Sept 1998 | - | -$2.70 M(-12.9%) | -$10.70 M(+9.2%) |
| June 1998 | -$9.80 M(+6.5%) | -$3.10 M(+19.2%) | -$9.80 M(+53.1%) |
| Mar 1998 | - | -$2.60 M(+13.0%) | -$6.40 M(-8.6%) |
| Dec 1997 | - | -$2.30 M(+27.8%) | -$7.00 M(-14.6%) |
| Sept 1997 | - | -$1.80 M(-700.0%) | -$8.20 M(-10.9%) |
| June 1997 | -$9.20 M(+55.9%) | $300.00 K(-109.4%) | -$9.20 M(-19.3%) |
| Mar 1997 | - | -$3.20 M(-8.6%) | -$11.40 M(+14.0%) |
| Dec 1996 | - | -$3.50 M(+25.0%) | -$10.00 M(+38.9%) |
| Sept 1996 | - | -$2.80 M(+47.4%) | -$7.20 M(+20.0%) |
| June 1996 | -$5.90 M | -$1.90 M(+5.6%) | -$6.00 M(+46.3%) |
| Mar 1996 | - | -$1.80 M(+157.1%) | -$4.10 M(+78.3%) |
| Dec 1995 | - | -$700.00 K(-56.3%) | -$2.30 M(+43.8%) |
| Sept 1995 | - | -$1.60 M | -$1.60 M |
FAQ
- What is Myriad Genetics annual net profit?
- What is the all time high annual net income for Myriad Genetics?
- What is Myriad Genetics annual net income year-on-year change?
- What is Myriad Genetics quarterly net profit?
- What is the all time high quarterly net income for Myriad Genetics?
- What is Myriad Genetics quarterly net income year-on-year change?
- What is Myriad Genetics TTM net profit?
- What is the all time high TTM net income for Myriad Genetics?
- What is Myriad Genetics TTM net income year-on-year change?
What is Myriad Genetics annual net profit?
The current annual net income of MYGN is -$263.30 M
What is the all time high annual net income for Myriad Genetics?
Myriad Genetics all-time high annual net profit is $176.20 M
What is Myriad Genetics annual net income year-on-year change?
Over the past year, MYGN annual net profit has changed by -$151.30 M (-135.09%)
What is Myriad Genetics quarterly net profit?
The current quarterly net income of MYGN is -$22.10 M
What is the all time high quarterly net income for Myriad Genetics?
Myriad Genetics all-time high quarterly net profit is $78.80 M
What is Myriad Genetics quarterly net income year-on-year change?
Over the past year, MYGN quarterly net profit has changed by +$39.20 M (+63.95%)
What is Myriad Genetics TTM net profit?
The current TTM net income of MYGN is -$116.00 M
What is the all time high TTM net income for Myriad Genetics?
Myriad Genetics all-time high TTM net profit is $187.85 M
What is Myriad Genetics TTM net income year-on-year change?
Over the past year, MYGN TTM net profit has changed by +$158.40 M (+57.73%)